* Zepp Health Corp ZEPP.N ZEPP.K is expected to show a
fall in
quarterly revenue when it reports results on May 11
(estimated).
* The Hefei Anhui-based company is expected to report a
16.0% decrease in revenue to CNY963.275 million from CNY1.15
billion a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Zepp Health Corp is
for
earnings of 39 fen per share. For the same quarter last year,
the company reported a loss of 46 fen per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Zepp Health
Corp
is $6.08, above its last closing price of $2.34.
This summary was machine generated May 9 at 18:31 GMT. All
figures in Chinese yuan renminbi unless otherwise stated